Cargando…
Tumor Cells Modified with Newcastle Disease Virus Expressing IL-24 as a Cancer Vaccine
Interleukin-24 (IL-24) is a promising agent for cancer immunotherapy that induces apoptosis of tumor cells and enhances T cell activation and function. In order to improve the antitumor activity induced by Newcastle disease virus (NDV)-modified tumor vaccine, we generated a recombinant NDV expressin...
Autores principales: | Xu, Xiaojing, Yi, Cheng, Yang, Xiaoqin, Xu, Jianwei, Sun, Qing, Liu, Yonghao, Zhao, Lixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630061/ https://www.ncbi.nlm.nih.gov/pubmed/31338417 http://dx.doi.org/10.1016/j.omto.2019.06.001 |
Ejemplares similares
-
Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
por: Xu, Xiaojing, et al.
Publicado: (2018) -
Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018) -
Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation
por: Xie, Peng, et al.
Publicado: (2020) -
Induction of antitumor response to fibrosarcoma by Newcastle disease virus-infected tumor vaccine
por: Takamura-Ishii, Mai, et al.
Publicado: (2017) -
Pathologic Mechanisms of the Newcastle Disease Virus
por: Zhang, Di, et al.
Publicado: (2023)